Compare BIRK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIRK | HAE |
|---|---|---|
| Founded | 1774 | 1971 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.8B |
| IPO Year | 2023 | 1996 |
| Metric | BIRK | HAE |
|---|---|---|
| Price | $34.32 | $119.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 11 |
| Target Price | $50.32 | ★ $124.50 |
| AVG Volume (30 Days) | ★ 1.7M | 620.2K |
| Earning Date | 08-13-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | $11.98 | $6.21 |
| Revenue Next Year | $13.81 | $5.54 |
| P/E Ratio | ★ $17.48 | $168.90 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.93 | $48.98 |
| 52 Week High | $50.73 | $123.77 |
| Indicator | BIRK | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 52.80 | 68.85 |
| Support Level | $33.06 | $100.92 |
| Resistance Level | $37.29 | N/A |
| Average True Range (ATR) | 1.07 | 3.35 |
| MACD | 0.34 | 1.12 |
| Stochastic Oscillator | 45.21 | 79.65 |
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.